APA (7th ed.) Citation

Martins, V., Fazal, L., Oganesian, A., Shah, A., Stow, J., Walton, H., & Wilsher, N. (2022). A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies. Xenobiotica, 52(8), 786. https://doi.org/10.1080/00498254.2022.2130838

Chicago Style (17th ed.) Citation

Martins, Vanessa, Lynsey Fazal, Aram Oganesian, Alpesh Shah, Jessie Stow, Hugh Walton, and Nicola Wilsher. "A Commentary on the Use of Pharmacoenhancers in the Pharmaceutical Industry and the Implication for DMPK Drug Discovery Strategies." Xenobiotica 52, no. 8 (2022): 786. https://doi.org/10.1080/00498254.2022.2130838.

MLA (9th ed.) Citation

Martins, Vanessa, et al. "A Commentary on the Use of Pharmacoenhancers in the Pharmaceutical Industry and the Implication for DMPK Drug Discovery Strategies." Xenobiotica, vol. 52, no. 8, 2022, p. 786, https://doi.org/10.1080/00498254.2022.2130838.